News

Dr. Shameka Shelby's New Role at Florida Southern College

Dr. Shameka Shelby's New Role at Florida Southern College

Florida Southern College Welcomes Dr. Shameka Shelby

Florida Southern College is thrilled to announce the appointment of Dr. Shameka Shelby as the Deputy Chief of Staff and Associate Vice President for Inclusive Excellence. Her new position is set to begin in September. With over a decade of experience at Florida Southern College, Dr. Shelby most recently held the position of Department Chair in Chemistry, Biochemistry, and Physics. In addition to her teaching responsibilities, she has also been recognized as the Dr. John A. Leighty Endowed Chair in Chemistry.

Leadership Praise from Dr. Jeremy P. Martin

Dr. Jeremy P. Martin, President of Florida Southern College, expressed his enthusiasm for Dr. Shelby’s appointment. He noted her impressive professional background and deep understanding of the institution. "I was delighted to discover someone ideally suited for this new role was already a valued member of our community. I look forward to seeing all that she will accomplish," he stated.

Dr. Shelby's Academic Journey

Dr. Shelby earned her B.S. in Biochemistry from Xavier University of Louisiana, followed by a Ph.D. in Biological Chemistry from the University of Michigan. Being a first-generation college graduate herself, she is passionate about mentoring students. Her research collaborations with undergraduates have led to many publications and conference presentations, highlighting her commitment to academic excellence.

Commitment to Inclusive Excellence

Expressing her excitement for her new role, Dr. Shelby said, "I am honored to step into the role of Deputy Chief of Staff and Associate Vice President for Inclusive Excellence at Florida Southern College. This unique position allows me to collaborate across the institution to advance strategic initiatives that enhance our impact and visibility while fostering a culture of inclusion where all students, faculty, and staff can thrive." Her previous roles include serving as the Associate Director of the Honors Program and leading various institutional initiatives aimed at student success.

Broad Impact of Her Role

Dr. Shelby has a proven track record of impactful leadership and collaboration in her contributions to the academic community. Her involvement in the Enrollment Management Committee and the General Education Curriculum Task Force demonstrates her commitment to aligning institutional values with strategic goals. Dr. Shelby has also played an active role in advancing diversity and inclusion efforts, most notably as a member of the DEIB Council.

Strategic Goals and Student Success

In her forthcoming position, Dr. Shelby is eager to help enhance the College's strategic goals through actionable initiatives aimed at boosting student success, faculty engagement, and overall institutional growth. "By leveraging the principles of inclusive excellence, I am excited to help align our strategic goals with meaningful actions. I look forward to creating an environment where everyone feels valued and empowered to contribute to our shared mission," she mentioned.

About Florida Southern College

Founded in 1883, Florida Southern College is the oldest private college in the state. It offers more than 70 undergraduate programs and distinctive graduate programs in business administration, education, nursing, and physical therapy. The College is recognized for its commitment to academic excellence and has a favorable student-to-faculty ratio of 14:1, which enhances engaged learning experiences. According to U.S. News & World Report's rankings, Florida Southern College is highly regarded among regional universities in the South and is commended for its innovation and value. Furthermore, Florida Southern is home to the largest collection of Frank Lloyd Wright architecture, contributing to its distinction as a beautiful campus.

Frequently Asked Questions

What position has Dr. Shameka Shelby been appointed to?

Dr. Shameka Shelby has been appointed as the Deputy Chief of Staff and Associate Vice President for Inclusive Excellence at Florida Southern College.

When will Dr. Shelby begin her new role?

Dr. Shelby will assume her new responsibilities in September.

What is Dr. Shelby's academic background?

Dr. Shelby holds a B.S. in Biochemistry from Xavier University of Louisiana and a Ph.D. in Biological Chemistry from the University of Michigan.

What initiatives has Dr. Shelby been involved in at Florida Southern College?

Dr. Shelby has contributed to various initiatives including serving as Associate Director of the Honors Program and leading efforts in the Enrollment Management Committee and the DEIB Council.

What is Florida Southern College known for?

Florida Southern College is known for its academic excellence, diverse program offerings, small student-to-faculty ratio, and as home to a significant collection of Frank Lloyd Wright architecture.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 19

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 24

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 30

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 18

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 25

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Showcases Innovation at Healthcare Event

Updated Category News Views 142

Alterity Therapeutics to Present at a Virtual Healthcare Conference Alterity Therapeutics, a biotechnology firm dedicated to developing treatments for neurodegenerative diseases, has recently announced its participation in an upcoming healthcare virtual conference. The event will shine a spotlight on influential healthcare companies and their innovative approaches to...

Continue Reading
Important Update for Toronto-Dominion Bank Investors on Lawsuit

Updated Category News Views 58

Update for Investors in Toronto-Dominion Bank Kahn Swick & Foti, LLC, led by the experienced former Louisiana Attorney General Charles C. Foti, Jr., is reminding investors that significant changes are arriving for shareholders of Toronto-Dominion Bank (NYSE: TD). As the legal landscape evolves, those who experienced losses may want to take immediate action regarding their...

Continue Reading
GCC's Quarterly Performance Analysis: Key Insights Revealed

Updated Category News Views 221

GCC Reports Significant First Quarter Financials GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a premier supplier and producer of cement, concrete, and aggregates, has shared its financial results for the first quarter. Despite facing various challenges, GCC's performance metrics reveal a resilience that is noteworthy. Q1 2025 Highlights In the first quarter of 2025, GCC...

Continue Reading
Indonesia's IDX Composite Index Declines Amid Market Pressures

Updated Category News Views 116

Overview of Recent Market Movements in Indonesia Indonesia's stock market experienced a downturn at the close of trading, influenced by various sectors showing significant losses. The IDX Composite Index reflected a decrease of 0.98%, marking a notable dip to a one-month low. This downturn is primarily attributed to declines in several key sectors, including...

Continue Reading
Blink Charging Achieves Advanced Certification for EV Chargers

Updated Category News Views 130

Blink Charging Receives Prestigious OCPP 2.0.1 Certification Blink stands out as one of just five EV charging companies in the U.S. to earn this coveted certification. Bowie, Md. – Blink Charging Co. (NASDAQ: BLNK), a prominent name in electric vehicle (EV) charging equipment and services, has proudly announced that its Series 7, 8, and 9 charger models have...

Continue Reading